Clinical Trial Update: Tocilizumab (TCZ) in New-onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tocilizumab for new-onset type 1 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Type 1 Diabetes Mellitus, New-onset Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2021-08-17